Loading insider details...
Beta
Latest Form 4 (Sep 20, 2024): Exercise/Conversion of 22,831 YMAB shares, $100.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 20, 2024 | Y-mAbs Therapeutics, Inc. (YMAB) | Exercise/Conversion | 22,831 | $100.0K |
| Sep 17, 2024 | Y-mAbs Therapeutics, Inc. (YMAB) | Sale | 65,000 | $875.5K |
| Jun 11, 2024 | Y-mAbs Therapeutics, Inc. (YMAB) | Sale | 35,000 | $421.1K |
| May 23, 2024 | Y-mAbs Therapeutics, Inc. (YMAB) | Sale | 25,000 | $300.0K |
| Mar 7, 2024 | Y-mAbs Therapeutics, Inc. (YMAB) | Sale | 3,900 | $64.1K |
| Jan 22, 2024 | Y-mAbs Therapeutics, Inc. (YMAB) | Grant/Award | 22,100 | n/a |